Lipe & Dalton’s Revvity RVTY Stock Holding History

Lipe & Dalton’s Portfolio RVTY Stock Details RVTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-225	Closed	-$45K	–	112
2021 Q4	$45K	Hold	225	–	–	0.02%	99
2021 Q3	$39K	Buy	225 +25	+13%	+$4.41K	0.02%	96
2021 Q2	$31K	Buy	+200	New	+$28.1K	0.02%	100

Other funds holding RVTY

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Lipe & Dalton's RVTY Position: Q1 2022 in Review

Lipe & Dalton sold out of Revvity (RVTY) in Q1 2022, closing a stake of 225 shares — an estimated $45K sold.

Lipe & Dalton first reported a position in RVTY in Q2 2021 and held it in 3 quarters. The position peaked at $45K in Q4 2021. 642 funds tracked by Wall St. Rank hold RVTY as of Q1 2022.

Lipe & Dalton reported no remaining Revvity position as of Q1 2022 after selling out during the quarter.
Lipe & Dalton sold 225 Revvity shares in Q1 2022, an estimated $45K.
Lipe & Dalton first reported a position in Revvity in Q2 2021 and held it in 3 quarters.
Lipe & Dalton's Revvity position peaked at $45K in Q4 2021.
642 funds tracked by Wall St. Rank held Revvity as of Q1 2022.

Based on Lipe & Dalton's 13F filing for Q1 2022, filed 26 Apr 2022.